Cripto-1 Antikörper (AA 38-188)
TDGF1.3
Reaktivität: Human
ELISA
Wirt: Maus
Monoclonal
7H257A
unconjugated
-
- Target Alle Cripto-1 (TDGF1.3) Produkte
- Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))
-
Bindungsspezifität
- AA 38-188
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cripto-1 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- Cripto-1 (Epidermal Growth Factor-Like Cripto Protein CR1, TDGF-1, Teratocarcinoma-Derived Growth Factor 1, CFC-2)
- Aufreinigung
- Purified by Protein G affinity chromatography.
- Endotoxin-Niveau
- Endotoxin: ≤0.1EU/ug (LAL)
- Immunogen
- Recombinant corresponding to aa38-188 from human Cripto-1 expressed in E. coli.
- Klon
- 7H257A
- Isotyp
- IgG1
-
anti-Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3) (Internal Region) antibody
TDGF1.3 Reaktivität: Human ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3) (Internal Region) antibodyTDGF1.3 Reaktivität: Human ELISA Wirt: Ziege Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with 1 mL sterile PBS.
- Buffer
- Supplied as a lyophilized powder from PBS, 5 % trehalose.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))
- Andere Bezeichnung
- Cripto-1 (TDGF1.3 Produkte)
-
Sie sind hier:
